Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06650813 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adapting the FACETS Program to Sickle Cell Disease

Study acronym: Drépa-FACETS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 19, 2025 (before its estimated May 2, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Primary and study completion dates: Nov 4, 2025 to May 2, 2026
    • Start date changed from estimate of Nov 4, 2024 to Jan 10, 2025
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).
Trial Details
NCT Number NCT06650813
Lead Sponsor Versailles Hospital
Collaborators: University Hospital, Grenoble, University Grenoble Alps, Paris Nanterre University
Conditions
(from sponsor)		 Fatigue Symptom, Sickle Cell Disease
Related terms Anemia, Sickle Cell, Fatigue
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov